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Objectives: Excessive blood loss during liver surgery contributes to postoperative morbidity and mor-
tality and the minimizing of blood loss improves outcomes. This study examines pre- and intraoperative
factors contributing to blood loss and identifies areas for improvement.
Methods: All patients who underwent elective hepatic resection between June 2007 and June 2009
were identified. Detailed information on the pre- and perioperative clinical course was analysed. Univari-
ate and multivariate analyses were used to identify factors associated with intraoperative blood loss.
Results: A total of 175 patients were studied, of whom 95 (54%) underwent resection of three or more
segments. Median blood loss was 782 ml. Greater blood loss occurred during major resections and
prolonged surgery and was associated with an increase in postoperative complications (P = 0.026). Peak
central venous pressure (CVP) of >10 cm H2O was associated with increased blood loss (P = 0.01).
Although no differences in case mix were identified, blood loss varied significantly among anaesthetists,
as did intraoperative volumes of i.v. fluids and transfusion practices.
Conclusions: This study confirms a relationship between CVP and blood loss in hepatic resection.
Intraoperative CVP values were higher than those described in other studies. There was variation in the
intraoperative management of patients. Collaboration between surgical and anaesthesia teams is
required to minimize blood loss and the standardization of intraoperative anaesthesia practice may
improve outcomes following liver surgery.
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Introduction
Liver resection offers the only possibility of cure for patients with
colorectal metastases1 and is an important treatment modality for
patients with hepatocellular carcinoma.2 Initial experiences in
hepatic resection were associated with significant morbidity and
mortality; however, increased understanding of hepatic segmental
anatomy and improvements in surgical equipment, associated
with the accumulation of surgical experience, have led to contin-
ued improvements in perioperative outcomes and most major
series now report mortality rates of <5%.3 As a result, liver resec-
tion is now seen as a first-line treatment in suitable patients.
Intraoperative blood loss is a predictor of perioperative
outcome following liver resection3,4 and may have an effect on
longterm disease-free survival.5,6 In addition to surgical tech-
niques such as total vascular exclusion, modifications of intra-
operative patient management procedures, such as low central
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venous pressure (CVP) anaesthesia and acute haemodilution,
have been shown to reduce blood loss and perioperative
morbidity.7,8
Many previous reports of liver resection series describe proce-
dures in which expertise was still being accumulated or centre on
small numbers of surgeons and anaesthetists, or refer to contexts
in which less advanced techniques were utilized.3,7 In the current
era of low CVP management and contemporary techniques, this
study sought to examine the factors in perioperative care that are
associated with blood loss and postoperative morbidity in an
established tertiary referral centre for hepatic surgery.
Materials and methods
Data were collected from the Lothian Surgical Audit database and
by retrospective case note review for patients who underwent liver
resection at the Royal Infirmary of Edinburgh between June 2007
and June 2009. A standardized data collection form was used.
Variables recorded included patient characteristics (age, gender,
diagnosis, comorbidities), surgical, anaesthetic and intraoperative
details, postoperative analgesia and i.v. fluids received, transfusion
on the day of surgery (including intraoperative transfusion and
transfusion administered in the anaesthesia recovery room), com-
plications and overall length of hospital stay. Major resections
were classified as those involving three or more segments. Com-
plications were recorded using the Dindo–Clavien classification
system.9 Intraoperative stability and volume status were assessed
by collecting the highest and lowest recorded CVPs during the
procedure, and the lowest recordedmean arterial pressure (MAP).
Operative blood loss was recorded at the end of the operation by
operating department staff. The names of surgeons and anaesthe-
tists were coded during data entry and the analyses were per-
formed in a blinded manner.
All data were entered into a database using Microsoft® Access
97. Data were analysed using spss Version 15.0 (SPSS, Inc.,
Chicago, IL, USA). The Mann–Whitney U-test was used for con-
tinuous variables and the chi-squared test for categorical vari-
ables. Data are presented as medians, with ranges in parentheses,
except when stated otherwise. Spearman rank correlation analysis
was performed to assess the relationship between peak and
minimum CVP and operative blood loss. All factors identified
on univariate analysis as predictive of operative blood loss of
1000 ml in major resections with a P-value of <0.1 were entered
into a backwards stepwise multiple logistic regression model.
Results
Population characteristics
Over the 2-year period studied, 190 patients were submitted to
liver resection. Comprehensive data were available for 175 (92%)
of these patients. Demographic data are presented in Table 1.
Operative details and blood loss
Complete blood loss data were available for 166 (95%) patients.
Intraoperative events and postoperative details are shown in
Table 2. Operative details and complication rates for all resections
stratified by blood loss are shown in Table 3. Underlying hepatic
fibrosis or steatosis had no significant bearing on blood loss.
Following the identification of an increased complication rate
in patients with greater blood loss, analysis was undertaken to
determine the pre- and intraoperative factors that might predict
greater blood loss in major resections. Greater losses were seen in
patients with hepatocellular carcinoma and cholangiocarcinoma.
Neither pre-existing comorbidity nor operating surgeon affected
blood loss, but the amount of blood loss was associated with the
anaesthetist involved. Assessment of the intraoperative volume
status of patients undergoing major resection revealed that higher
peak CVP levels were associated with greater rates of blood loss of
1000 ml (P = 0.010) and peak CVP was weakly correlated with
operative blood loss (Fig. 1). Analysis of preoperative laboratory
results did not show any relationship between prothrombin time
or platelets and bleeding.
Logistic regression was performed to establish which indices
were independent predictors of blood loss of 1000 ml. Two
factors remained independently significant: CVP of >10 cm H2O,
and the responsible anaesthetist (P = 0.02) (Table 4). The regres-
sion model showed no lack of fit to the model (Hosmer–
Lemeshow test, P = 0.963), but limited predictive value
(Nagelkerke R2 = 0.354).
Table 1 Patient demographics and comorbidities (n = 175)
Variable
Age, years, median (range) 61 (19–84)
Gender, male, n (%) 92 (52.6%)
ASA grade, n (%)
I 23 (13.1%)
II 115 (65.7%)
III 28 (16.0%)
IV 1 (0.6%)
Not stated 8 (4.6%)
Smoker, n (%) 35 (20.0%)
Diagnosis, n (%)
Metastatic colorectal cancer 106 (60.6%)
Cholangiocarcinoma 10 (5.7%)
Hepatocellular carcinoma 22 (12.6%)
Benign lesion 16 (9.1%)
Other malignant lesion 21 (12.0%)
Comorbidity, n (%)
Diabetes mellitus 17 (9.7%)
Hypertension 50 (28.6%)
Ischaemic heart disease 17 (9.7%)
Cerebrovascular disease 6 (3.4%)
Chronic obstructive pulmonary disease 2 (1.1%)
ASA, American Society of Anesthesiologists.
HPB 237
HPB 2012, 14, 236–241 © 2012 International Hepato-Pancreato-Biliary Association
Blood transfusion
Transfusion practices varied among anaesthetists. A total of 45
patients (26%) received blood on the day of surgery. Five anaes-
thetists administered blood only to patients in whom the total
blood loss was >1500 ml. However, two anaesthetists took a more
liberal approach to blood administration and transfused patients
with lesser blood loss (minimum blood losses resulting in trans-
fusions of 205 ml and 885 ml, respectively). Fifteen of the 62
patients under the care of these two anaesthetists received blood
transfusions despite having lost <1500 ml of blood; these
accounted for 15 of the 16 patients in whom blood loss was below
this threshold and who received transfusions (Table 5).
Patients who received a blood transfusion on the day of surgery
were more likely to suffer a postoperative complication (22 of 45
vs. 38 of 130; P = 0.001) and to have a prolonged hospital inpatient
stay (median stay 6 days vs. 9 days; P < 0.001), and had a greater
likelihood of in-hospital mortality (four of 45 vs. two of 130;
P = 0.039). There was no difference in baseline clotting character-
istics between patients who received transfusions and those who
did not.
Discussion
This study demonstrates a relationship between CVP and blood
loss in hepatic resection and suggests that the standardization of
intraoperative management may improve outcomes associated
with liver surgery.
The link between higher CVP values and greater intraoperative
blood loss during parenchymal transection would appear to be
intuitive. However, this has not been consistently demonstrated in
previous studies because only approximately half of the published
series have shown higher CVP to have an effect.10–12 This is one of
the largest studies to show that CVP correlates with blood loss.
Several recent studies on living donor liver transplantation
(LDLT) have found that CVP had no effect on blood loss13,14 and
some have advocated that CVP monitoring is not required in this
type of surgery.15 However, this may relate to absolute CVP level.
The findings of older studies correlating high CVP and blood loss7
have been adopted by these LDLT centres, which actively strive to
maintain low target CVPs.13–15
The positioning of the pressure transducer is an important
consideration in the interpretation of CVP because the relation-
ship between the CVP transducer and the operative site will
change depending on the segmental location of the resection and
the physical dimensions of the liver.16
The data recorded in the present study represent maximum and
minimum CVP levels, collected retrospectively from anaesthesia
charts. The optimal index measurement is CVP during parenchy-
mal transection, taking into account other factors such as positive
end-expiratory pressure and transducer position. However, in this
study the highest recorded CVP was predictive of blood loss. The
strength of the association between CVP and blood loss might
have been improved if transection CVP had been used; this
measurement should be used in any future prospective study.
Variations in anaesthesia practice within and among institu-
tions have been demonstrated previously in liver transplanta-
tion17,18 and in open heart surgery.19 This study found that
practices in intraoperative fluid administration and blood trans-
fusion differed within a group of anaesthetists experienced in the
care of patients undergoing hepatic resection.
Intraoperative fluid administration varied among anaesthetists.
There is increasing evidence that volume restrictionmay influence
outcomes in critical care andmajor surgery.20 A recent randomized
controlled clinical trial in cardiac surgery demonstrated that
restrictive intraoperative fluid regimens are associated with
reduced operative blood loss.21 In liver surgery, many centres have
embraced a policy of restricted fluid administration.8,13,22 From
this retrospective study, it is not possible to ascertain whether
the relationship between intraoperative fluid administration and
blood loss reflects one of cause or of effect, but the differences
seen among different anaesthetists may suggest that it reflects
inter-individual practice. Restricted fluid administration does not
impair renal function in hepatic surgery22 and the current evidence
would appear to favour a restrictive regimen in liver resection.
The overall transfusion rate in this series was 26%. The pub-
lished literature describes highly variable rates of transfusion,
which vary according to centre and the years for which data are
analysed, and typically range from 17% to 50%.3,4,23 Although the
overall transfusion rates in this study compare well with those of
other studies, it is interesting to note that there were differences in
Table 2 Intraoperative events and postoperative course
Operating time, min, median (range) 220 (50–735)
Estimated blood loss, ml, median (range) 800 (25–15 000)
Extent of resection, n (%)
Minor (<3 segments) 80 (45.7%)
Major (3 segments) 95 (54.3%)
Intraoperative fluids, ml, median (range) 2000 (500–14 400)
Peak CVP, cm H2O, median (range) 10 (2–17)
Minimum CVP, cm H2O, median (range) 5 (-3–13)
Transfusion on day of surgery, n (%) 45 (25.7%)
Length of ICU stay, days, median (range) 0 (0–23)
Length of HDU stay, days, median (range) 3 (0–8)
Length of hospital stay, days, median (range) 6 (2–58)
Complications, n (%) 60 (34.3%)
Dindo–Clavien grade of complication, n (%)
I 19 (10.9%)
II 23 (13.1%)
IIIa 4 (2.3%)
IIIb 5 (2.9%)
IVa 1 (0.6%)
IVb 2 (1.1%)
V 6 (3.4%)
CVP, central venous pressure; ICU, intensive care unit; HDU, high depen-
dency unit.
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transfusion triggers among anaesthetists. Variable transfusion
practices have been noted both within and among institutions in
liver transplantation.17,18 A relationship between increased trans-
fusion rates and poorer postoperative outcomes has been demon-
strated repeatedly in liver surgery. However, it remains unclear
whether or not this simply reflects more difficult surgery.
Although this study did not assess the transfusion trigger on a
case-by-case basis, the implementation of a unit-wide agreement
on transfusion triggers might reduce transfusion heterogeneity in
this patient group.
There are a number of interventions to change transfusion
practices which have been used previously in different settings,
albeit with mixed levels of success.24 An international definition
and grading of the severity of post-hepatectomy haemorrhage has
been proposed to facilitate the comparison of results from differ-
ent studies.25 Similarly, standardized grading of intraoperative
blood loss could be applied to operative blood loss and replace-
ment to facilitate and standardize the reporting of complications
in future trials.
The anaesthetist has previously been recognized as a risk factor
in cardiac surgery.26,27 No effect of anaesthetists on mortality or
morbidity emerged in this study, but it is insufficiently powered to
make such an assessment. There were no differences among anaes-
thetists in overall case mix and the relationship between anaesthe-
tist and blood loss may reflect variations in intraoperative
management and may be attributable to the amount of crystalloid
administered intraoperatively or to CVP management.
This study has a number of limitations. These include its ret-
rospective nature, potential unaccounted bias and the way in
Table 3 Operative details and complication rates for all resections stratified by blood loss
Blood loss, ml
0–500 (n = 54) 501–999 (n = 42) 1000 (n = 79) P-valuea
Major resection, n (%) 10 (18.5%) 24 (57.1%) 61 (77.2%) <0.001
Operative time, min, median (range) 150 (50–270) 235 (105–500) 285 (140–735) <0.001
Intraoperative crystalloid, ml, median (range) 1000 (200–3000) 1250 (260–3000) 2000 (900–7000) 0.001
Intraoperative colloid, ml, median (range) 0 (0–2000) 875 (0–2000) 1500 (0–7000) <0.001
Complications, n (%) 11 (20.4%) 14 (33.3%) 34 (43.0%) 0.026
In-hospital stay, days, median (range) 6 (2–18) 6 (3–58) 7 (4–54) <0.001
aChi-squared test.
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Figure 1 Correlation between blood loss and peak central venous
pressure (CVP) showing a weak association between peak CVP
and increased blood loss (P = 0.023, Spearman's rank coefficient
R = 0.253)
Table 4 Univariate and multivariate analyses of pre- and intraopera-
tive factors and associations with blood loss of 1000 ml in major
resections (3 segments)
Variable OR 95% CI P-value
Univariate analysis
1 comorbidity 1.017 0.408–2.535 0.971
Peak CVP >10 cm H2O 3.339 1.340–8.310 0.010
Minimum CVP <5 cm H2O 1.314 0.556–3.101 0.534
Age >70 years 0.636 0.219–1.848 0.406
Albumin <35 0.385 0.041–3.635 0.404
Bilirubin >16 2.50 0.62–10.10 0.198
Platelets <150 1.870 0.349–10.000 0.465
Prothrombin time >12 s 1.793 0.552–5.250 0.331
Multivariate analysis
CVP >10 cm H2O 5.52 1.70–17.20 0.003
Anaesthetist 0.020
1 1 – –
2 0.036 0.002–0.670 0.026
3 0.01 0.00–0.26 0.006
4 0.10 0.10–1.04 0.054
5 0.111 0.004–2.780 0.181
6 0.278 0.025–3.162 0.302
7 0.600 0.049–7.407 0.691
OR, odds ratio; 95% CI, 95% confidence interval; CVP, central venous
pressure.
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which CVP was recorded (peak CVP). Furthermore, the true trig-
gers for blood ordering and administration in individual patients
cannot be established. It will be essential to test the findings of this
study in a prospective controlled study. In addition to improving
the detail of CVP measurement (mean, peak and transectional
CVP), such a study should seek to definitively identify the factors
that trigger blood transfusion, including the assessment of the
speed of blood loss, intraoperative haemoglobin levels and the
time and point of blood ordering.
In conclusion, this study identified variations in the intraopera-
tive management of patients undergoing liver surgery which were
associated with increased operative blood loss. Collaboration
between surgical and anaesthesia teams and the development of
standardized protocols may contribute to the minimizing of
blood loss and improve the outcomes associated with liver
surgery.
Conflicts of interest
None declared.
References
1. Garden OJ, Rees M, Poston GJ, Mirza D, Saunders M, Ledermann J et al.
(2006) Guidelines for resection of colorectal cancer liver metastases. Gut
55 (Suppl. 3):iii1–iii8.
2. Jarnagin W, Chapman WC, Curley S, D'Angelica M, Rosen C, Dixon E
et al. (2010) Surgical treatment of hepatocellular carcinoma: expert
consensus statement. HPB 12:302–310.
3. Jarnagin WR, Gonen M, Fong Y, DeMatteo RP, Ben-Porat L, Little S et al.
(2002) Improvement in perioperative outcome after hepatic resection:
analysis of 1,803 consecutive cases over the past decade. Ann Surg
236:397–406.
4. Poon RT, Fan ST, Lo CM, Liu CL, Lam CM, Yuen WK et al. (2004)
Improving perioperative outcome expands the role of hepatectomy in
management of benign and malignant hepatobiliary diseases: analysis
of 1222 consecutive patients from a prospective database. Ann Surg
240:698–708.
5. Stephenson KR, Steinberg SM, Hughes KS, Vetto JT, Sugarbaker PH,
Chang AE. (1988) Perioperative blood transfusions are associated with
decreased time to recurrence and decreased survival after resection of
colorectal liver metastases. Ann Surg 208:679–687.
6. Asahara T, Katayama K, Itamoto T, Yano M, Hino H, Okamoto Y et al.
(1999) Perioperative blood transfusion as a prognostic indicator in
patients with hepatocellular carcinoma. World J Surg 23:676–680.
7. Jones RM, Moulton CE, Hardy KJ. (1998) Central venous pressure and
its effect on blood loss during liver resection. Br J Surg 85:1058–
1060.
8. Balci ST, Pirat A, Torgay A, Cinar O, Sevmis S, Arslan G. (2008) Effect of
restrictive fluid management and acute normovolemic intraoperative hae-
modilutionon transfusion requirements during living donor hepatectomy.
Transplant Proc 40:224–227.
9. Dindo D, Demartines N, Clavien PA. (2004) Classification of surgical
complications: a new proposal with evaluation in a cohort of 6336
patients and results of a survey. Ann Surg 240:205–213.
10. Wang WD, Liang LJ, Huang XQ, Yin XY. (2006) Low central venous
pressure reduces blood loss in hepatectomy. World J Gastroenterol
12:935–939.
11. Chen H, Merchant NB, Didolkar MS. (2000) Hepatic resection using
intermittent vascular inflow occlusion and low central venous pressure
anaesthesia improves morbidity and mortality. J Gastrointest Surg 4:162–
167.
12. Johnson M, Mannar R, Wu AV. (1998) Correlation between blood loss and
inferior venacaval pressure during liver resection. Br J Surg 85:188–
190.
13. Kim YK, Chin JH, Kang SJ, Jun IG, Song JG, Jeong SM et al. (2009)
Association between central venous pressure and blood loss during
hepatic resection in 984 living donors. Acta Anaesthesiol Scand 53:601–
606.
Table 5 Transfusion practices of different anaesthetists. Analysis was performed only in 159 patients for whom complete data were available
and who were cared for by the ‘usual’ anaesthetists. Case mix data include those patients for whom blood loss data were unavailable
Anaesthetist
1 2 3 4 5 6 7 Total P-valuea
Patients, n 17 11 12 49 8 38 24 159
Patients transfused, n 8 1 0 14 2 7 10 42 0.036
Minimum blood loss resulting in transfusion, ml 1630 2000 N/A 205 1500 2300 885 N/A N/A
Patients transfused with blood loss 1500 ml, n 0/9 0/10 0/11 9/43 1/7 0/28 6/19 16/127 N/A
Patients transfused with blood loss >1500 ml, n 8/8 1/1 0/1 5/6 1/1 7/10 4/5 26/32 N/A
Median blood loss, ml 1200 400 568 705 750 813 1173 800 (25–15 000)b 0.028
Intraoperative crystalloid, ml 1000 1000 1000 1000 2000 1500 2000 1500 (200–7000)b <0.001
Intraoperative colloid, ml 1000 0 1000 1000 500 750 1000 1000 (0–7000)b 0.285
Total intraoperative fluids, ml 2000 1500 2000 2000 3000 2000 3500 2000 (500–12 000)b 0.011
Case mix, n
Major resections 9 6 6 28 3 22 16 90
Minor resections 9 5 7 23 5 17 9 75
aKruskal–Wallis test.
bMedian (range).
N/A, not available.
240 HPB
HPB 2012, 14, 236–241 © 2012 International Hepato-Pancreato-Biliary Association
14. Chhibber A, Dziak J, Kolano J, Norton JR, Lustik S. (2007) Anaesthesia
care for adult live donor hepatectomy: our experiences with 100 cases.
Liver Transpl 13:537–542.
15. Niemann CU, Feiner J, Behrends M, Eilers H, Ascher NL, Roberts JP.
(2007) Central venous pressure monitoring during living right donor hepa-
tectomy. Liver Transpl 13:266–271.
16. Giordano C, Deitte LA, Gravenstein N, Rice MJ. (2010) What is the
preferred central venous pressure zero reference for hepatic resection?
Anesth Analg 111:660–664.
17. Massicotte L, Sassine MP, Lenis S, Roy A. (2004) Transfusion predictors
in liver transplant. Anesth Analg 98:1245–1251.
18. Ozier Y, Pessione F, Samain E, Courtois F; French Study Group on Blood
Transfusion in Liver Transplantation. (2003) Institutional variability in
transfusion practice for liver transplantation. Anesth Analg 97:671–679.
19. Karkouti K, Wijeysundera DN, Beattie WS, Callum JL, Cheng D, Dupuis
JY et al.; Reducing Bleeding in Cardiac Surgery (RBC) Research Group.
(2007) Variability and predictability of large-volume red blood cell trans-
fusion in cardiac surgery: a multicentre study. Transfusion 47:2081–2088.
20. Adesanya A, Rosero E, Timaran C, Clagett P, Johnston WE. (2008)
Intraoperative fluid restriction predicts improved outcomes in major vas-
cular surgery. Vasc Endovascular Surg 42:531–536.
21. Vretzakis G, Kleitsaki A, Stamoulis K, Bareka M, Georgopoulou S,
Karanikolas M et al. (2010) Intraoperative intravenous fluid restriction
reduces perioperative red blood cell transfusion in elective cardiac
surgery, especially in transfusion-prone patients: a prospective, random-
ized controlled trial. J Cardiothorac Surg 5:7.
22. Melendez JA, Arslan V, Fischer ME, Wuest D, Jarnagin WR, Fong Y et al.
(1998) Perioperative outcomes of major hepatic resections under low
central venous pressure anaesthesia: blood loss, blood transfusion,
and the risk of postoperative renal dysfunction. J Am Coll Surg 187:620–
625.
23. Cockbain AJ, Masudi T, Lodge JP, Toogood GJ, Prasad KR. (2010)
Predictors of blood transfusion requirement in elective liver resection.
HPB 12:50–55.
24. Tinmouth A. (2007) Reducing the amount of blood transfused by chang-
ing clinicians' transfusion practices. Transfusion 47 (Suppl. 2):132–
136.
25. Rahbari NN, Garden OJ, Padbury R, Maddern G, Koch M, Hugh TJ et al.
(2011) Post-hepatectomy haemorrhage: a definition and grading by the
International Study Group of Liver Surgery (ISGLS). HPB 13:528–535.
26. Slogoff S, Keats AS. (1985) Does perioperative myocardial ischaemia
lead to postoperative myocardial infarction? Anesthesiology 62:107–
114.
27. Merry AF, Ramage MC, Whitlock RM, Laycock GJ, Smith W, Stenhouse
D et al. (1992) First-time coronary artery bypass grafting: the anaesthetist
as a risk factor. Br J Anaesth 68:6–12.
HPB 241
HPB 2012, 14, 236–241 © 2012 International Hepato-Pancreato-Biliary Association
